Brief: Matinas Biopharma Holdings Reports Q1 Loss Per Share Of $0.05

Matinas BioPharma Holdings

10/05/2018 12:10

May 10 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.05
    * MATINAS - EXPECTS TO COMMENCE PIVOTAL PHASE 2
ADAPTIVE-DESIGNED
STUDY FOR MAT2203 FOLLOWING ITS NEXT INTERACTION WITH FDA IN
FIRST HALF OF 2019
    * ENDED QUARTER WITH CASH AND CASH EQUIVALENTS OF
APPROXIMATELY
$4.3 MILLION
    * COMPANY BELIEVES THAT CASH ON HAND IS SUFFICIENT TO FUND
OPERATIONS INTO SEPTEMBER 2018

Source text for Eikon:  ID:nGNX36J677 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))